Chemokine receptor expression on allergen-specific T cells in asthma and allergic bronchopulmonary aspergillosis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 62, Issue 2, 2007, Pages 170-177

  Garcia, G ^a,b   Humbert, M ^a,b   Capel, F ^b   Rimaniol, A C ^b   Escourrou, P ^a   Emilie, D ^b   Godot, V ^b  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b INSERM   (France)

Author keywords

Allergic bronchopulmonary aspergillosis; Asp f specific CD4 T lymphocytes; Aspergillus fumigatus; Chemokine receptors

Indexed keywords

ALLERGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4;

ADULT; AGED; ALLERGIC ASTHMA; ANTIGEN SPECIFICITY; ARTICLE; BRONCHOPULMONARY ASPERGILLOMA; CD4+ T LYMPHOCYTE; CELL SPECIFICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DERMATOPHAGOIDES PTERONYSSINUS; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; LYMPHOCYTE PROLIFERATION; MALE; PHLEUM PRATENSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

AGED; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS FUMIGATUS; ASTHMA; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; RECEPTORS, CHEMOKINE; T-LYMPHOCYTES;

EID: 33846169407     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2006.01216.x     Document Type: Article

References (30)

1. Tillie-Leblond I, Tonnel AB. Allergic bronchopulmonary aspergillosis. Allergy 2005;60:1004-1013.
2. Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002;110:685-692.
3. Mastella G, Rainisio M, Harms HK, Hodson ME, Koch C, Navarro J et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. Eur Respir J 2000;16:464-471.
4. Humbert M, Durham SR, Ying S, Kimmitt P, Barkans J, Assoufi B et al. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med 1996;154:1497-1504.
5. Humbert M, Menz G, Ying S, Corrigan CJ, Robinson DS, Durham SR et al. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol Today 1999;20:528-533.
6. Knutsen AP, Hutchinson PS, Albers GM, Consolino J, Smick J, Kurup VP. Increased sensitivity to IL-4 in cystic fibrosis patients with allergic bronchopulmonary aspergillosis. Allergy 2004;59:81-87.
7. Kay AB. Allergy and allergic diseases. Second of two parts. N Engl J Med 2001;344:109-113.
8. Larche M, Robinson DS, Kay AB. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 2003;111:450-463; quiz 464.
9. Krug N, Tschernig T, Holgate S, Pabst R. How do lymphocytes get into the asthmatic airways? Lymphocyte traffic into and within the lung in asthma. Clin Exp Allergy 1998;28:10-18.
10. Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol 2001;2:123-128.
11. Mackay CR. Chemokines: immunology's high impact factors. Nat Immunol 2001;2:95-101.
12. Lloyd C. Chemokines in allergic lung inflammation. Immunology 2002;105:144-154.
13. Humbert M, Ying S, Corrigan C, Menz G, Barkans J, Pfister R et al. Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony- stimulating factor, and IL-3. Am J Respir Cell Mol Biol 1997;16:1-8.
14. Ying S, Meng Q, Zeibecoglou K, Robinson DS, Macfarlane A, Humbert M et al. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics. J Immunol 1999;163:6321-6329.
15. Elsner J, Escher SE, Forssmann U. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases. Allergy 2004;59:1243-1258.
16. Banwell ME, Robinson DS, Lloyd CM. Adenoid-derived TH2 cells reactive to allergen and recall antigen express CC chemokine receptor 4. J Allergy Clin Immunol 2003;112:1155-1161.
17. Sallusto F, Lanzavecchia A, Mackay CR. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 1998;19:568-574.
18. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998;187:129-134.
19. Zingoni A, Soto H, Hedrick JA, Stoppacciaro A, Storlazzi CT, Sinigaglia F et al. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol 1998;161:547-551.
20. Gonzalo JA, Lloyd CM, Peled A, Delaney T, Coyle AJ, Gutierrez-Ramos JC. Critical involvement of the chemotactic axis CXCR4/stromal cell-derived factor-1 alpha in the inflammatory component of allergic airway disease. J Immunol 2000;165:499-508.
21. Lukacs NW, Berlin A, Schols D, Skerlj RT, Bridger GJ. AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity. Am J Pathol 2002;160:1353-1360.
22. Rimaniol AC, Garcia G, Till SJ, Capel F, Gras G, Balabanian K et al. Evaluation of CD4+ T cells proliferating to grass pollen in seasonal allergic subjects by flow cytometry. Clin Exp Immunol 2003;132:76-80.
23. Nouri-Aria KT, Wilson D, Francis JN, Jopling LA, Jacobson MR, Hodge MR et al. CCR4 in human allergen-induced late responses in the skin and lung. Eur J Immunol 2002;32:1933-1938.
24. Campbell JJ, Brightling CE, Symon FA, Qin S, Murphy KE, Hodge M et al. Expression of chemokine receptors by lung T cells from normal and asthmatic subjects. J Immunol 2001;166:2842-2848.
25. Sallusto F, Kremmer E, Palermo B, Hoy A, Ponath P, Qin S et al. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur J Immunol 1999;29:2037- 2045.
26. Kallinich T, Schmidt S, Hamelmann E, Fischer A, Qin S, Luttmann W et al. Chemokine-receptor expression on T cells in lung compartments of challenged asthmatic patients. Clin Exp Allergy 2005;35:26-33.
27. Panina-Bordignon P, Papi A, Mariani M, Di Lucia P, Casoni G, Bellettato C et al. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest 2001;107:1357-1364.
28. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998;187:875-883.
29. Kunkel EJ, Boisvert J, Murphy K, Vierra MA, Genovese MC, Wardlaw AJ et al. Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am J Pathol 2002;160:347-355.
30. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998;101:746-754.